And the opportunity cost of not only the last 2 years, but potentially the next 6-12 months as well.
The “look at all the other biotechs” doesn’t really hold weight with me, there’s a ton of opportunity out there experiencing strong growth. You only have to look towards the resource sector
The eventual pay off gets eroded further IMO the longer this takes.
And the opportunity cost of not only the last 2 years, but...
-
- There are more pages in this discussion • 7,445 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.62 |
Change
0.015(0.93%) |
Mkt cap ! $276.0M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.55 | $456.4K | 284.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 2659 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |